Bio Protocol vs Falcon Finance — how do they compare? Bio Protocol trades at Rp443.9 (market cap Rp1,01T, Rp174,27M 24h volume), while Falcon Finance trades at Rp1,160 (market cap Rp3,56T, Rp204,91M 24h volume). The key difference: Falcon Finance is far larger — about 3.5× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 3,1B / 10B FF (31%) for Falcon Finance. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 17 Days and Falcon Finance for 8 Days on average.
| BIO | FF | |
|---|---|---|
Market Cap | Rp1,01T | Rp3,56T |
Volume (24h) | Rp174,27M | Rp204,91M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 3,1B / 10B FF (31%) |
Typical Hold Time | 17 Days | 8 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp424.33 with a market cap of Rp965.85M, showing neutral technical signals amid bearish moving averages. The token's circulating supply of 2.3M out of 3.3M max indicates 69% circulation with an average hold time of 17 days. Recent technical indicators show mixed signals with RSI in neutral territory while ADX suggests some buying momentum. Support and resistance levels are well-defined between Rp398 and Rp500.
Overall outlook remains neutral with key opportunities in protocol adoption growth, though risks include limited liquidity and typical crypto volatility. Investors should monitor network activity closely as the token operates in a competitive blockchain ecosystem without major recent protocol updates.
Falcon Finance (FF) is trading at Rp1,146.42 with a market cap of Rp3.52T, showing a bullish technical signal supported by moving averages and oscillators. The token has a circulating supply of 3.1M out of 10M max, with key support at Rp1,040 and resistance at Rp1,304. Recent on-chain activity indicates moderate network usage, though no major protocol upgrades were reported in the last month.
Overall outlook is cautiously optimistic due to strong technical indicators and stable tokenomics, but risks include low liquidity and regulatory uncertainty in Indonesia. Key opportunities lie in potential ecosystem growth, while major risks involve high volatility and limited exchange depth.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Falcon Finance is developing a universal collateral infrastructure that transforms any liquid asset—such as digital assets, currency-backed tokens, and tokenized real-world assets—into USD-pegged on-chain liquidity. The native token of the protocol, FF, serves as a gateway to governance, staking rewards, community incentives, and exclusive access to unique products and features.
Read more on FF →